Middle East & Africa Dry Eye Products Market

The Middle East & Africa dry eye products market was valued at US$ 151.86 million in 2023 and is expected to reach US$ 179.24 million by 2031; it is estimated to register a CAGR of 2.1% from 2023 to 2031.

Ongoing Research and Growing Pipeline for Dry Eye Products Bolster Middle East & Africa Dry Eye Products Market

The dry eye condition is expected to be seen in the majority of the population across the world in the coming years. Many research studies have proven dry eye as a life-style disease. Improvements or changes in daily habits such as sleep, diet, and exercise are included in the treatment of dry eyes. Additionally, the stressful life among people across the world is likely to increase the incidences of dry eyes. Therefore, the rising incidences of dry eyes are expected to propel the demand for dry eye products in the coming years.

The advancement in technology has resulted in increased product development. Various companies are entering the market, which is contributing greatly to enhance market growth. Various companies have designed various innovative formulae to offer better eye drops for dry eye conditions. The cycle of product development is continuous and is likely to act as a vital growth factor during the forecast period. For instance, in 2019, Aldeyra Therapeutics had enrolled for the RENEW phase three clinical trial for its reproxalap ophthalmic solution (0.25%) to treat moderate to severe dry eye conditions. Similarly, Novaliq has two products in pipelines, such as NOVO3 (100% perfluorohexyloctane) and CyclASol (ophthalmic solution of 0.1% cyclosporine A in EyeSol).

Some companies are focusing on innovating other forms of products that can treat dry eye conditions. For instance, in October 2018, Oyster Point Pharma has a nasal spray which is in phase three clinical trial for the treatment of DED. The product is developed from the compound OC–01, which is highly selective nicotinic acetylcholine receptor (nAChR) agonist, which targets the parasympathetic nervous system and controls tear film homeostasis partially through the trigeminal nerve. The company is expected to submit a new drug application (NDA) in 2020. Thus, such innovations are likely to act as trending factors and are expected to contribute significantly to the market growth in the coming years.

Middle East & Africa Dry Eye Products Market Overview

The dry eye products market in the Middle East & Africa is segmented into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. The increase in prevalence of eye diseases in the geriatric population, rising cases of diabetes, and surging incidence of dry eye disease and cataract in countries such as Saudi Arabia and the UAE is fueling market growth in the region.

Saudi Arabia has a higher prevalence of dry eye diseases, Environmental factors such as desert climate with a temperature reaching more than 50°C in summers act as risk factors for dry eye conditions. Trachoma was also an endemic disease in some parts of Saudi Arabia. The country government is implementing campaigns and community-based education programs that are influential for eye health promotion strategies. The strategies help raise awareness and encourage the community to pay attention to eye health. The Ministry of Health (MoH) provides educational messages on eye diseases; this helps educate people about diseases such as cataracts, glaucoma, amblyopia, and diabetic retinopathy. These government initiatives for awareness are fueling the growth of eye drops market in Saudi Arabia.

Middle East & Africa Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Dry Eye Products Strategic Insights

Strategic insights for the Middle East & Africa Dry Eye Products provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Dry Eye Products Report Scope

Middle East & Africa Dry Eye Products Regional Insights

The geographic scope of the Middle East & Africa Dry Eye Products refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Dry Eye Products Market Segmentation 

The Middle East & Africa dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the Middle East & Africa dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Middle East & Africa dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the Middle East & Africa dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Middle East & Africa dry eye products market share in 2023.

By type, the Middle East & Africa dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Middle East & Africa dry eye products market share in 2023.

Based on distribution channel, the Middle East & Africa dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Middle East & Africa dry eye products market share in 2023.

Based on country, the Middle East & Africa dry eye products market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the Middle East & Africa dry eye products market.